Metraipolis › archive › dc_f1fee4c4e09f

Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myeloma — Europe PMC PMID:41345095

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41345095
DOI: 10.1038/s41408-[numero omesso]-9
License (as archived): solo-consultazione
Archived: 2026-11-07T22:09:49.336Z
SHA-256 of the archived text: 480c3b8b32e34b122dc22a95e85979d7ac1a90a0a2b544ac1ac57c7364e40fb5
Stable URL of this page: https://metraipolis.com/documento/dc_f1fee4c4e09f

How to cite

Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myeloma — Europe PMC PMID:41345095 — Europe PMC (en), https://europepmc.org/article/MED/41345095 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f1fee4c4e09f (Metraipolis archive dc_f1fee4c4e09f, sha256 480c3b8b32e34b122dc22a95e85979d7ac1a90a0a2b544ac1ac57c7364e40fb5)

BibTeX

@misc{dcf1fee4c4e09f,
  title = {Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myeloma — Europe PMC PMID:41345095},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41345095},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f1fee4c4e09f; sha256 480c3b8b32e34b122dc22a95e85979d7ac1a90a0a2b544ac1ac57c7364e40fb5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41345095. Agents can read the archived copy with the MCP tool read_document.